Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000930413-18-000522
Filing Date
2018-02-16
Accepted
2018-02-15 18:50:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 c90534_sc13d.htm SC 13D 154602
  Complete submission text file 0000930413-18-000522.txt   156113
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-44055 | Film No.: 18619172
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830 203 971-3300
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D